Response to letter ‘Lymphocyte counts and the risk of COVID-19 in people with MS’

Abstract

Get full access to this article

View all access options for this article.

References

Loonstra

Hoitsma

Van Kempen

ZLE

, et al. COVID-19 in multiple sclerosis: The Dutch experience. Mult Scler 2020; 26: 1256–1260.

Brownlee

Bourdette

Broadley

, et al. Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic. Neurology 2020; 94: 949–952.

Louapre

Collongues

Stankoff

, et al. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol 2020; 77: 1–10.

Evangelou

Garjani

dasNair

, et al. Self-diagnosed COVID-19 in people with multiple sclerosis: A community-based cohort of the UK MS register. J Neurol Neurosurg Psychiatry. Epub ahead of print 27 August 2020. DOI: 10.1136/jnnp-2020-324449.